Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Thoracic Malignancies
•
Medical Oncology
•
Thymoma and Thymic Carcinoma
Is there a role for surgical debulking, local RT or subsequent line of chemotherapy for a patient with stable malignant thymoma but active myasthenia gravis?
Related Questions
For patients with metastatic thymic carcinoma, is there a role for local treatment options such as SBRT for oligoprogressive or oligopersistent disease after systemic therapy?
What second line therapy do you use for metastatic thymoma that recurs following CAP?
Which regimen do you recommend for chemoradiation for a patient with locally advanced, inoperable thymic tumor in the setting of CKD Stage III?
Would you consider omission of PORT for node+ NSCLC with a positive margin in the setting of a high tumor PD-L1 score and plans for immunotherapy?
What are your top takeaways from ESMO 2023?
How would you treat Stage III unresectable adenocarcinoma of the lung with a BRAF-V600E mutation?
Is there a role for surgical debulking for patients with stage IV lung sarcomatoid carcinoma?
What is your approach for an RA patient with lung cancer who is starting immunotherapy?
What would be your approach in a patient who presented with a solitary brain metastasis that resolved after chemo without local therapy?
Did NRG LU004 demonstrate safety with hypofractionated lung radiation and concurrent ICI?
